Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lora Barke"'
Autor:
Charles E. Leonard, Yunfei Wang, Lina Asmar, Rachel Y. Lei, Kathryn T. Howell, Phyllis L. Henkenberns, Timothy K. Johnson, Tracy L. Hobart, Shannon P. Tole, Jane M. Kercher, Jodi L. Widner, Lora Barke, Terese Kaske, Dennis L. Carter
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7089-7100 (2021)
Abstract Purpose/Objective The primary objective is to examine patient self‐assessment of breast pain and cosmesis between three‐dimensional (3D‐CRT) versus intensity‐modulated radiotherapy (IMRT). The secondary objective is to evaluate any r
Externí odkaz:
https://doaj.org/article/df9360285429476a8a0b62eae7f1c431
Autor:
Anabel Goulding, Lina Asmar, Yunfei Wang, Shannon Tole, Lora Barke, Jodi Widner, Charles Leonard
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeTo report a primary objective clinical outcome of ipsilateral breast recurrence following accelerated partial breast irradiation (APBI) in women with triple negative and other high risk breast cancer (as described in 2017 ASTRO guidelines) (i.
Externí odkaz:
https://doaj.org/article/e11318a248014780a9827e5bd7144f0e
Autor:
Lora Barke, Jodi L. Widner, Anabel Goulding, Lina Asmar, Charles E. Leonard, Shannon P. Tole, Yunfei Wang
Publikováno v:
Cancer Research. 80:P2-13
Purpose: To report a primary objective clinical outcome of ipsilateral breast recurrence following accelerated partial breast irradiation (APBI) in cautionary (as described in 2017 revised ASTRO APBI guidelines) and high-risk women (age Methods and M
Autor:
Charles E. Leonard, Anabel Goulding, Yunfei Wang, Shannon P. Tole, Lora Barke, Lina Asmar, Jodi L. Widner
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
PurposeTo report a primary objective clinical outcome of ipsilateral breast recurrence following accelerated partial breast irradiation (APBI) in women with triple negative and other high risk breast cancer (as described in 2017 ASTRO guidelines) (i.
Autor:
Yunfei Wang, RD Sobus, S.P. Fryman, K. Howell, Lina Asmar, Jodi L. Widner, Dennis L. Carter, Scot Sedlacek, Lora Barke, Charles E. Leonard, Jane Kercher
Publikováno v:
Cancer Research. 77:P1-10
PURPOSE: Primary objective: patient self-assessment of breast pain between 3-dimensional radiotherapy (3D-CRT) versus intensity modulated radiotherapy (IMRT). Secondary objectives: breast cosmesis as well as local-regional recurrence and survival sta
Autor:
Andrea G. Freitas, A. Thomas Stavros, Marilia C. V. de Campos, Giselle G. N. deMello, Lora Barke, Daniela Stanzani, Arnold Honick, Adriana Helena Padovan, Terese Kaske, Dennis McDonald, Ana Paula C. Moura, Ducly Wolverton
Publikováno v:
European radiology. 27(10)
We assessed multiple readers’ positive predictive values (PPVs) for ACR BI-RADS 3, 4a, 4b, 4c and 5 masses on ultrasound (US) pre- and post-proposed guidelines. This retrospective, IRB-approved study included four American and four non-American rea
Autor:
Kathryn Howell, Tracy L. Hobart, Timothy D. Johnson, Jane Kercher, Scot Sedlacek, Michael Tallhamer, Charles E. Leonard, Terese Kaske, Lora Barke, Dennis L. Carter
Publikováno v:
Clinical breast cancer. 11(3)
Purpose To examine the outcome of breast cancer patients who have prior breast augmentation treated with lumpectomy followed by accelerated partial breast external intensity-modulated radiotherapy (APBIMRT) with image-guided radiotherapy (IGRT). Meth
Autor:
Charles E. Leonard, P. Henkenberns, Lora Barke, R.M. LaPorte, S.P. Fryman, Jodi L. Widner, Rachel Y. Lei, Dennis L. Carter, R.D. Higdon, K. Howell
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 87:S196
RTOG/EORTC Late Radiation Morbidity systems were used for evaluation of skin, subcutaneous and non-cutaneous toxicities. Median follow-up was 82.5 months (range, 2-104 months). Results: At 4 years, the physician rating of overall cosmesis was good or